General Assembly has approved the strategy of LZVO for the next year

On November 22, 2021, a General Assembly of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2022 were approved, as well as a report on the most significant work done this year was presented.

The General Assembly approved the budget for 2022 and the annual flat fee for marketing authorization holders (MAHs) in accordance with the financing policy for the maintenance and development of the Latvian Medicines Verification System, approved at the Board meeting on April 21, 2021. The fixed flat fee per each MAH set by the General Assembly for the next year is 3,500 euros.

The main priority of LZVO in 2022 will be the maintenance and further development of the medicines verification system. Among the most significant tasks in this area are related to the purchase, installation, and qualification of the national Alert Management System (AMS), connection of it to the European central AMS, as well as connection of end users to the AMS and their training. Also, next year LZVO plans to pay more attention to cash flow planning and cost control to streamline expenses and create financial savings for LZVO.

The most important tasks of LZVO in 2021 include the development of new versions of the verification system and interfaces, testing and handing over to users, improvement of quality management and operational procedures, introduction of guidelines for the investigation of alerts, as well as constant cooperation with the end users of the system to ensure the safe distribution of medicine in legal supply chain of Latvia.

The Association “Latvian Medicines Verification Organisation” (LZVO) was established in December 2016 with the aim to establish, maintain and manage the Latvian Medicines Verification System in accordance with the requirements of the European Medicines Verification System, the Falsified Medicines Directive, and the Delegated Regulation. The founders of the association are professional associations of medicines manufacturers, wholesalers, pharmacies, and other industries involved in the circulation of medicines: Association of International Research-based Pharmaceuticals Manufacturers, The Latvian Generic Medicines Association, the Latvian Association of Pharmaceutical Wholesalers, the Latvian Association of Pharmaceutical Care and the Latvian Medicines Parallel Import Association.

More information:

Inese Erdmane

Chairwoman of the Board at LZVO